31 December 2024

Tag: young investors

Can scrappy Valeo Pharma (VPH.C) win a Stanley Cup?

“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives,” stated Saviuk.

12 December 2020
NeuPath Health Inc (NPTH.V)- undervalued medical play, solving one of Canada’s hardest problems

There’s a million ways to invest, and we’ve covered most of them. You could follow Warren Buffett’s market moves, commit to a specific pattern and philosophy, invest according to your astrology chart that morning… (we would like to officially recommend you not do the latter) At Equity Guru, we like to find companies that follow…

12 September 2020
That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster

“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”

5 September 2020
Valeo Pharma Inc. (VPH.C) – THE undervalued biotech play

If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38% returns on your investment. Better yet, if you had bought Valeo’s stock a month ago, you would have been up close to 184%, which, y’know, is…

24 July 2020